96 related articles for article (PubMed ID: 11678376)
1. High-performance liquid chromatographic assay for abacavir and its two major metabolites in human urine and cerebrospinal fluid.
Ravitch JR; Moseley CG
J Chromatogr B Biomed Sci Appl; 2001 Oct; 762(2):165-73. PubMed ID: 11678376
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study.
McDowell JA; Chittick GE; Ravitch JR; Polk RE; Kerkering TM; Stein DS
Antimicrob Agents Chemother; 1999 Dec; 43(12):2855-61. PubMed ID: 10582871
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
Veldkamp AI; Sparidans RW; Hoetelmans RM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):123-8. PubMed ID: 10676991
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of abacavir in plasma and cerebrospinal fluid.
Capparelli EV; Letendre SL; Ellis RJ; Patel P; Holland D; McCutchan JA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2504-6. PubMed ID: 15917556
[TBL] [Abstract][Full Text] [Related]
5. Quantitative determination of (-)-2'-deoxy-3'-thiacytidine (lamivudine) in human plasma, saliva and cerebrospinal fluid by high-performance liquid chromatography with ultraviolet detection.
Hoetelmans RM; Profijt M; Mennhorst PL; Mulder JW; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):387-94. PubMed ID: 9746254
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of abacavir and zidovudine from rat tissues using HPLC with ultraviolet detection.
Lewis SR; White CA; Bartlett MG
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):45-52. PubMed ID: 17118723
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
Verweij-van Wissen CP; Aarnoutse RE; Burger DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):121-9. PubMed ID: 15664342
[TBL] [Abstract][Full Text] [Related]
8. Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.
Hughes W; McDowell JA; Shenep J; Flynn P; Kline MW; Yogev R; Symonds W; Lou Y; Hetherington S
Antimicrob Agents Chemother; 1999 Mar; 43(3):609-15. PubMed ID: 10049275
[TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults.
Kumar PN; Sweet DE; McDowell JA; Symonds W; Lou Y; Hetherington S; LaFon S
Antimicrob Agents Chemother; 1999 Mar; 43(3):603-8. PubMed ID: 10049274
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of HBY 097 and its metabolites in human serum and urine by HPLC.
Agarwal VK; Krol GJ; Krone V; Roberts D
J Pharm Biomed Anal; 1998 Mar; 16(7):1195-203. PubMed ID: 9571537
[TBL] [Abstract][Full Text] [Related]
11. Determination of abacavir in human plasma by high-performance liquid chromatography with ultraviolet detection and the analytical error function.
Ferrer SM; Modamio P; Lastra CF; Mariño EL
Biomed Chromatogr; 2004 Dec; 18(10):862-5. PubMed ID: 15386566
[TBL] [Abstract][Full Text] [Related]
12. Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume.
Sarasa M; Riba N; Zamora L; Carné X
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):183-9. PubMed ID: 11076070
[TBL] [Abstract][Full Text] [Related]
13. Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection.
Hoetelmans RM; van Essenberg M; Meenhorst PL; Mulder JW; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):235-41. PubMed ID: 9367213
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration.
Calcagno A; Pinnetti C; De Nicolò A; Scarvaglieri E; Gisslen M; Tempestilli M; D'Avolio A; Fedele V; Di Perri G; Antinori A; Bonora S
Br J Clin Pharmacol; 2018 Jun; 84(6):1380-1383. PubMed ID: 29444348
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection.
Sparidans RW; Hoetelmans RM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 2001 Jan; 750(1):155-61. PubMed ID: 11204216
[TBL] [Abstract][Full Text] [Related]
16. Determination of nevirapine, an HIV-1 non-nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography.
Hollanders RM; van Ewijk-Beneken Kolmer EW; Burger DM; Wuis EW; Koopmans PP; Hekster YA
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):65-71. PubMed ID: 10985567
[TBL] [Abstract][Full Text] [Related]
17. A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients.
Dailly E; Reliquet V; Victorri-Vigneau C; Raffi F; Jolliet P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):317-20. PubMed ID: 16497564
[TBL] [Abstract][Full Text] [Related]
18. Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.
Saras-Nacenta M; López-Púa Y; Lípez-Cortés LF; Mallolas J; Gatell JM; Carné X
J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):53-9. PubMed ID: 11710583
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.
Aouri M; Barcelo C; Ternon B; Cavassini M; Anagnostopoulos A; Yerly S; Hugues H; Vernazza P; Günthard HF; Buclin T; Telenti A; Rotger M; Decosterd LA;
Drug Metab Dispos; 2016 Jan; 44(1):151-61. PubMed ID: 26553012
[TBL] [Abstract][Full Text] [Related]
20. Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.
Jullien V; Tréluyer JM; Chappuy H; Dimet J; Rey E; Dupin N; Salmon D; Pons G; Urien S
Br J Clin Pharmacol; 2005 Feb; 59(2):183-8. PubMed ID: 15676040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
